# DAPSONE

NDC: 59651-666
Generic name: DAPSONE
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: GEL
Routes: TOPICAL
Marketing started: 20250404

FDA application: ANDA218457

## Active ingredients

- DAPSONE: 50 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59651-666"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59651-666
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acd33f0b-8563-467a-93db-a11902331528